Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
At its General Meetings held on 5 May 2026, ArcelorMittal shareholders approved key corporate actions including a US$0.60 per share dividend distribution, re-election of current directors along with a new director, approval of share cancellation following buybacks, and renewal of board authorization to increase share capital. These approvals suppor…
Huntington Ingalls Industries reported first quarter fiscal 2026 revenues of $3.1 billion, up 13.4% year-over-year, driven by growth across its shipbuilding and mission technology segments. Despite higher revenues, operating margins declined slightly, leading to net earnings and diluted EPS of $149 million and $3.79 respectively, unchanged from the…
Sow Good Inc. announced a $20 million non-convertible private placement credit facility with Sagol Advisors to fund its strategic acquisition of the Nachu Graphite Project in Tanzania. This funding supports Sow Good's transition into critical minerals and battery anode materials development, enhancing its position in the battery materials supply ch…
Broadcom is trading like a safe growth name but with meaningful upside if management hits its AI revenue cadence. The company generates ~$29B of free cash flow, has a $1.97T market cap and a stretched P/E near 80, creating a trade opportunity for disciplined buyers. We lay out an entry at $420, a stop at $380 and a target at $545 for a long-term tr…
Coinbase Global said it will reduce its global headcount by roughly 700 employees, about 14% of its workforce as of May 1, 2026, as part of a restructuring aimed at lowering operating costs and aligning the business for the AI era. The company expects the program to be substantially complete in the second quarter of 2026 and estimates total restruc…
IREN Limited said Tuesday it has signed a definitive agreement to acquire Mirantis, a cloud infrastructure and Kubernetes orchestration provider, in a transaction valued at about $625 million paid in IREN ordinary shares. The deal is aimed at strengthening IREN's AI Cloud delivery by improving deployment, monitoring, support and market access for e…
Cellectar Biosciences saw its shares jump 130% in pre-market trading after announcing an oversubscribed financing package that could provide up to $140 million to advance its radiotherapeutic candidate iopofosine I 131 toward a confirmatory study and an FDA accelerated approval filing for Waldenström macroglobulinemia.
Meta Platforms said on May 5 it will extend technology that identifies and places suspected teenage accounts into Teen Account protections to 27 European Union countries and will apply the system to Facebook in the United States, with rollout to the UK and EU planned in June. The company described using advanced AI to analyze profile context and to…
PayPal reported first-quarter results that exceeded analyst expectations as continued consumer spending supported payment volumes. Revenue rose 7% to $8.35 billion and adjusted earnings per share were $1.34, ahead of consensus. Management under new CEO Enrique Lores outlined a reorganization and plans to cut roughly $1.5 billion in costs over the n…
Morgan Stanley upgraded SSAB AB (ST:SSABa) to overweight from equal-weight, increasing its price target to SKr 94 from SKr 73 and placing the stock on its Top Pick list in place of ArcelorMittal. The bank pointed to improving earnings momentum, robust conditions in the U.S. plate market, and a relatively lower sensitivity to energy costs as key dri…
Fiserv, Inc. reported first quarter 2026 GAAP revenue of $5.03 billion, down 2% year-over-year, with organic revenue down 4%. GAAP EPS declined 29%, and adjusted EPS fell 16%. The company confirmed 2026 organic revenue growth guidance of 1%-3% and adjusted EPS between $8.00 and $8.30. Operating margins declined notably compared to prior year period…
Arvinas, a biotechnology company specializing in targeted protein degradation therapies, announced it will release its first quarter 2026 financial results on May 12, 2026, accompanied by a corporate update webcast. The company continues advancing multiple clinical-stage investigational drugs, including FDA-approved VEPPANU developed with Pfizer fo…
Relmada Therapeutics announced presentations of two abstracts related to NDV-01, their sustained-release gemcitabine-docetaxel formulation for non-muscle invasive bladder cancer (NMIBC), at the American Urology Association 2026 event. Phase 2 data in high-risk NMIBC patients showing 9-12 month efficacy results will be presented, alongside a Phase 3…
NeurAxis, Inc., a medical technology company specializing in neuromodulation therapies, will release its first quarter 2026 financial results on May 12, 2026, prior to market open. The company will also host a conference call to discuss the results and business update. NeurAxis focuses on the commercialization of its proprietary PENFS technology, I…
Repligen Corporation reported a robust first quarter 2026 with revenues of $194 million, up 15% year-over-year, and adjusted EPS growth of 23%. The company reiterated its full-year organic revenue growth guidance of 9%-13%, while increasing adjusted EPS guidance to $1.97-$2.05. Key strategic moves include launching a Transformation Office to enhanc…
Colliers International Group Inc. announced robust first quarter 2026 financial results, with consolidated revenues rising 15% to $1.31 billion and adjusted EBITDA increasing by 8% to $124.8 million. Adjusted EPS grew 5% to $0.91, reflecting the company's diversified professional services platform's resilience amid an uneven operating environment. …
BellRing Brands announced second quarter fiscal 2026 results showing net sales increase of 2% year-over-year to $598.7 million driven by volume growth. However, operating profit and net earnings declined significantly, impacted by an $11 million inventory-related charge and increased costs including freight and promotional investments. The company …
Axsome Therapeutics, a biopharmaceutical company specializing in treatments for central nervous system disorders, will present at the BofA Securities 2026 Health Care Conference and RBC Capital Markets Global Healthcare Conference in May 2026. The company focuses on novel therapies addressing significant neurological and psychiatric conditions and …
Kymera Therapeutics reported new preclinical data demonstrating that KT-579, an oral IRF5 degrader, showed potent disease-modifying activity in inflammatory bowel disease models, performing comparably or better than current therapies. The ongoing Phase 1 trial in healthy volunteers is expected to yield data in the second half of 2026, supporting th…
Tilray Brands' BrewDog has entered a 12-month partnership with Underbelly to become the official beer supplier at key UK venues and festivals such as Underbelly at the Edinburgh Fringe, Christmas in Trafalgar Square, and Underbelly Boulevard Soho. This partnership offers BrewDog expanded reach and visibility at major live entertainment events, enha…
Regeneron Pharmaceuticals and Sanofi reported positive results from the REMODEL Phase 4 trial showing that Dupixent (dupilumab) significantly improves esophageal distensibility and reduces disease-related structural and inflammatory changes in adult patients with eosinophilic esophagitis (EoE). These findings reinforce Dupixent's role in treating t…
Shopify announced its financial results for Q1 2026, highlighting a 34% year-over-year revenue growth and crossing $100 billion in Gross Merchandise Volume (GMV). The company maintained a 15% free cash flow margin and expects continued growth in Q2 2026 with high twenties percentage revenue increase. Shopify emphasizes its competitive edge by lever…
FactSet's Board of Directors announced an increase in the quarterly dividend from $1.10 to $1.16 per share, continuing its long-standing commitment to shareholder returns. This marks the 27th consecutive year of dividend increases on a stock split-adjusted basis, highlighting the company's strong financial performance and stability. The dividend wi…
Autolus Therapeutics plc, a US-listed commercial stage biopharmaceutical company specializing in next-generation programmed T cell therapies, will release its Q1 2026 financial results on May 14, 2026, before US market open. The company will also host a conference call and webcast to discuss financial outcomes and provide a business update.
GLOBALFOUNDRIES reported Q1 2026 financial results showing revenue of $1.634 billion with solid profitability metrics exceeding guidance. The company launched its SCALE optical module for co-packaged optics and expanded a strategic partnership with Renesas Electronics, enhancing its presence in automotive and data center markets. GF also announced …
